Base excision repair initiated rolling circle amplification-based fluorescent assay for screening uracil-DNA glycosylase activity using Endo IV-assisted cleavage of AP probes

The Analyst
Jingfeng WangJiadong Huang

Abstract

Uracil-DNA glycosylase (UDG) is a crucial damage repair enzyme that initiates the cellular base excision repair pathway that maintains the integrity of the genome. Abnormal UDG activity may induce the malfunction of uracil excision repair that is directly related to a range of diseases including cancers, genotypic diseases, and human immunodeficiencies. In this work, a simple, robust and cost effective biosensing platform for the ultrasensitive detection of UDG activity is established based on the combination of base excision repair-initiated primer generation for rolling circular amplification (RCA) with Endo IV-assisted signal amplification. In the presence of target UDG, UDG can catalyze the removal of uracil on a hairpin probe (HP) leaving an apurinic/apyrimidinic (AP site) which can be cleaved by Endo IV to generate a primer for triggering the RCA reaction. Subsequently, numerous AP site-embedded signal probes, acting as fluorescence-quenched probes, combine with the RCA products to perform signal transduction and quadradic signal amplification through an Endo IV-catalyzed cleavage reaction, thus significantly enhancing the fluorescence signal, which can be used for UDG activity screening. Under optimum conditions, this bi...Continue Reading

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J TchouS Nishimura
Sep 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·T Lindahl
May 18, 2001·Nature·J H Hoeijmakers
Jan 24, 2002·Nature·Alexander A Ischenko, Murat K Saparbaev
May 26, 2004·Biochemical and Biophysical Research Communications·Andrei MaksimenkoMurat K Saparbaev
Feb 13, 2013·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Hua ZhangRuqin Yu
Dec 4, 2013·Journal of the American Chemical Society·Qian JinHenry S White
Dec 11, 2013·Biosensors & Bioelectronics·Marc A McWilliamsJason D Slinker
Sep 25, 2014·Protein Science : a Publication of the Protein Society·N SchormannD Chattopadhyay
Jan 30, 2015·The Analyst·Seyed Vahid HamidiGholamreza Tavoosidana

❮ Previous
Next ❯

Methods Mentioned

BETA
deamination
biosensing
biosensors
nucleic acid amplification
electrophoresis
biosensor
fluorescence
fluorescence assay

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.